iNewz.in Hindi News

Covaxin Gets Shelf Life Extension Up To 12 Months, Central Drugs Standard Control Organization Approved The Extension – Covaxin Shelf Life Extension: Covaxin can be used for one year from the date of production

PTI, New Delhi

Published by: Surendra Joshi
Updated Wed, 03 Nov 2021 04:34 PM IST

Summary

Indigenous vaccine maker Bharat Biotech said on Wednesday that the Central Drugs Standard Control Organization (CDSCO) has extended the shelf life of its anti-Covid vaccine Covaxin by 12 months.

Indigenous vaccine maker Bharat Biotech said on Wednesday that the Central Drugs Standard Control Organization (CDSCO) has extended the shelf life of its anti-Covid vaccine Covaxin by 12 months. That is, Covaxin can now be used within a year from the date of production.

Bharat Biotech tweeted on Wednesday that CDSCO has extended the shelf life of Covaxin to 12 months. The Drugs Control Organization has made this decision based on additional stability data provided by the company. Bharat Biotech has developed indigenous Covaxin vaccine against Corona. The company has informed its shareholders about the increase in shelf life.

Recently Australia approved, WHO has not yet given
Recently the Australian government has approved the Covaxin vaccine. However, Covaxin has not yet been approved by the World Health Organization. The company had applied for emergency use in April.

People taking Covaxin supplements are not being allowed to travel in many countries due to the lack of global approval. In most countries, only those people are being entered, who have received a dose of vaccine included in the WHO list internationally. However, some countries are approving this indigenous vaccine from India. Estonia, Kyrgyzstan, Palestine, Mauritius and Mongolia have also recently approved Covaxin.

Expansion

Indigenous vaccine maker Bharat Biotech said on Wednesday that the Central Drugs Standard Control Organization (CDSCO) has extended the shelf life of its anti-Covid vaccine Covaxin by 12 months. That is, Covaxin can now be used within a year from the date of production.

Bharat Biotech tweeted on Wednesday that CDSCO has extended the shelf life of Covaxin to 12 months. The Drugs Control Organization has made this decision based on additional stability data provided by the company. Bharat Biotech has developed indigenous Covaxin vaccine against Corona. The company has informed its shareholders about the increase in shelf life.

Recently Australia approved, WHO has not yet given

Recently the Australian government has approved the Covaxin vaccine. However, Covaxin has not yet been approved by the World Health Organization. The company had applied for emergency use in April.

People taking Covaxin supplements are not being allowed to travel in many countries due to the lack of global approval. In most countries, only those people are being entered, who have received a dose of vaccine included in the WHO list internationally. However, some countries are approving this indigenous vaccine from India. Estonia, Kyrgyzstan, Palestine, Mauritius and Mongolia have also recently approved Covaxin.

.

Leave a Reply